CareLit · DOI-Nachweis · Das Gesundheitswesen
Publicly accessible evidence of health related quality of life benefits associated with cancer drugs approved by the European Medicines Agency between 2009 and 2015
DOI 10.1055/s-0040-1708976
Bibliografische Angaben
Nachweis in CareLit
Autor:innenGrössmann, N.; Robausch, M.; Rothschedl, E.; Wild, C.; Simon, J.
ZeitschriftDas Gesundheitswesen
Ausgabe5/2020
Jahrgang / SeitenJg. 82 · S. 1 bis 1
Kernaussage aus der Literatur
Abstract-Vorschau
Background Health-related quality of life (HRQoL) is one of the most important patient-relevant study endpoints for the direct measurement of the benefit of cancer drugs. Therefore, our aim was to detect cancer indications with no published information on HRQoL at the time of European Medicines Agency (EMA) approval and monitor any reported HRQoL evidence updates after at least three years follow-up. Methods We incl…
Zitieren
Zitierempfehlung
Grössmann, N.; Robausch, M.; Rothschedl, E.; Wild, C.; Simon, J (2020) Publicly accessible evidence of health related quality of life benefits associated with cancer drugs approved by the European Medicines Agency between 2009 and 2015. Das Gesundheitswesen, 82 (5), 1 bis 1. https://doi.org/10.1055/s-0040-1708976
Mit CareLit weiterarbeiten